Adapet began its journey in revolutionizing pet diabetes care by initiating internal prototype testing for its Continuous Glucose Monitoring (CGM) system. This phase focused on validating the core sensor technology,...
Adapet began its journey in revolutionizing pet diabetes care by initiating internal prototype testing for its Continuous Glucose Monitoring (CGM) system. This phase focused on validating the core sensor technology,...
Adapet officially launched its Phase I clinical usability and safety study, involving a select group of diabetic dogs under veterinary supervision. The trial aimed to explore the user experience from...
Adapet officially launched its Phase I clinical usability and safety study, involving a select group of diabetic dogs under veterinary supervision. The trial aimed to explore the user experience from...
With its prototype refined, Adapet conducted blind-wear tests in veterinary hospitals, focusing on long-duration wear, motion friction response, skin sensitivity, and behavior observation. At the same time, the product’s visual...
With its prototype refined, Adapet conducted blind-wear tests in veterinary hospitals, focusing on long-duration wear, motion friction response, skin sensitivity, and behavior observation. At the same time, the product’s visual...
Adapet’s digital companion—the CGM mobile app—entered its full-stack development phase. The company defined a modular development approach, assigning responsibilities to Jiunuo for UI/UX, backend integration for real-time sensor data, and...
Adapet’s digital companion—the CGM mobile app—entered its full-stack development phase. The company defined a modular development approach, assigning responsibilities to Jiunuo for UI/UX, backend integration for real-time sensor data, and...
In this critical clinical validation stage, Adapet initiated multi-week trials with 5–10 diabetic dogs and cats, using the CGM device in daily living conditions while collecting comparative BGM data. The...
In this critical clinical validation stage, Adapet initiated multi-week trials with 5–10 diabetic dogs and cats, using the CGM device in daily living conditions while collecting comparative BGM data. The...
Adapet’s medical and scientific teams finalized the standard operating procedures (SOPs) and data frameworks for the upcoming Phase III clinical trial. This included protocols for multi-center testing, data anonymization, baseline...
Adapet’s medical and scientific teams finalized the standard operating procedures (SOPs) and data frameworks for the upcoming Phase III clinical trial. This included protocols for multi-center testing, data anonymization, baseline...
Een selectie kiezen resulteert in het geheel verversen van de pagina.